Traders should prepare for potential volatility around the April 29 earnings release. Monitor actual EPS and revenue versus the low consensus bar ($0.00 EPS, $28.1M revenue) and listen for updates on Osteoarthritis Pain Management or Regenerative Solutions segments.
Price Chart
Executive Summary
Anika Therapeutics announced it will release Q1 2026 financial results on April 29, 2026, ahead of market open, followed by a conference call. The press release contains no actual financial results for the quarter; it is purely an earnings announcement.
Key Facts
- Anika Therapeutics (ANIK) will release Q1 2026 financial results on April 29, 2026, before market open.
- Conference call scheduled for 8:30 a.m. ET on April 29, 2026.
- No financial results were disclosed in this press release — only logistical details for the upcoming earnings announcement.
- Pre-release consensus estimates: EPS $0.00, Revenue $28.1M (1 analyst).
Financial Impact
None disclosed — this filing is an earnings announcement, not a results release.
Risk Factors
- Low analyst coverage (only 1 analyst) increases risk of outsized reaction to any deviation from expectations.
- No financial data provided here — actual results could be positive or negative, creating uncertainty.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3274855 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Jul 29, 2026 9w ago | 8-K | $16.17 $21.68 | ▲ +34.08% | ▲ +29.06% | $19.10 (+18.12%) |
Jul 14, 2026 11w ago | 8-K | $15.93 $22.03 | ▲ +38.29% | ▲ +35.95% | $19.10 (+19.90%) |
Jun 23, 2026 14w ago | 8-K | $14.73 $15.01 | ▲ +1.90% | ▼ −0.03% | $19.10 (+29.67%) |
Jun 11, 2026 16w ago | Institutional Cluster | $14.72 $15.60 | ▼ −5.98% | ▼ −4.20% | $19.10 (−29.76%) |
Jun 8, 2026 16w ago | DEFA14A | $14.60 $16.03 | ▲ +9.79% | ▲ +8.16% | $19.10 (+30.82%) |
Jun 1, 2026 17w ago | DEFA14A | $14.63 $14.63 | · 0.00% | ▲ +1.30% | $19.10 (+30.55%) |
Apr 30, 2026 22w ago | Insider Cluster | $12.45 $14.90 | ▲ +19.68% | ▲ +14.71% | $19.10 (+53.41%) |
Apr 29, 2026 22w ago | 8-K | $12.39 $14.90 | ▲ +20.26% | ▲ +14.21% | $19.10 (+54.16%) |
Apr 28, 2026 22w ago | DEFA14A | $12.39 $14.90 | ▲ +20.26% | ▲ +14.21% | $19.10 (+54.16%) |
Apr 15, 2026 24w ago | Press Release | $15.39 $14.80 | ▼ −3.83% | ▼ −9.65% | $19.10 (+24.11%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access